DRAGSA 96 LLC 3
3 · Amylyx Pharmaceuticals, Inc. · Filed Jan 21, 2022
Insider Transaction Report
Form 3
DRAGSA 96 LLC
10% Owner
Holdings
- 2,300,000
Common Stock
Footnotes (1)
- [F1]The following persons affiliated with DRAGSA 96 LLC separately reported these securities on Form 4 filed January 13, 2022: Andreas Halvorsen, David C. Ott, Rose S. Shabet, Viking Global Investors LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, and Viking Global Opportunities Illiquid Investments Sub-Master LP.